FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Clozaril (clozapine) to update its labeling. The change is related to the product's labeling information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• CLOZARIL (Clozapine)

Snippet

SUPPL AP for CLOZARIL (CLOZAPINE)